Ing Investment Management »

Lexeo Therapeutics shares owned by Ing Investment Management

Quarter-by-quarter ownership of Lexeo Therapeutics (LXEO) shares owned by Ing Investment Management from 13F filings

Historical chart of Ing Investment Management investment in Lexeo Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lexeo Therapeutics held by Ing Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexeo Therapeutics by Ing Investment Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $109k 11k 9.93

More positions owned by Ing Investment Management

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Wisdomtree Tr Voya Yld Enhncd (UNIY)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl C (GOOG)
Lam Research Corp Com New (LRCX)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Wells Fargo & Company (WFC)

View all positions for Ing Investment Management

Top funds holding Lexeo Therapeutics

Henderson Group
BlackRock
Paradigm Biocapital Advisors
Vestal Point Capital
Frazier Life Sciences Management
Balyasny Asset Management
Vanguard Group
Citadel Advisors
venBio Select Advisor
Affinity Asset Advisors
Woodline Partners
State Street Corporation
Millennium Management
OrbiMed Advisors
Point72 Asset Management

View all funds holding Lexeo Therapeutics